Loss of Response to Anti-Tumor Necrosis Factor Alpha Therapy in Crohn’s Disease Is Not Associated with Emergence of Novel Inflammatory ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2018-01-25

AUTHORS

Jay Luther, Manish Gala, Suraj J. Patel, Maneesh Dave, Nynke Borren, Ramnik J. Xavier, Ashwin N. Ananthakrishnan

ABSTRACT

BackgroundWhile monoclonal antibodies against tumor necrosis factor-α (TNFα) are effective in treating Crohn’s disease (CD), approximately one-third of patients lose response. The mechanisms underlying this loss of response remain elusive.AimWe sought to determine if novel biological pathways, including TNFα-independent inflammatory pathways, emerge in those with loss of response to anti-TNFα.MethodsUsing RNA microarray technology in 28 patients with CD, we examined the colonic gene expression differences between those with active inflammation in the setting of loss of response to TNFα-antagonist therapy (“loss of responders”) compared to anti-TNFα naïve patients with active inflammation and those on anti-TNF therapy in disease remission. Pathway enrichment analyses were performed.ResultsWe found that colonic expression of chemokines known to drive inflammation (CXCL20, CXCL9, and CXCL10) was elevated in those with loss of response compared to those in remission. Expression of genes critical to modulating oxidative stress burden (DUOX2, DUOXA2, and NOS2) was also elevated. Additionally, MMP3, MMP1, and MMP12 were elevated in those with continued inflammation. Gene enrichment analysis revealed that loss of responders exhibited dysregulation in the cysteine and methionine metabolism pathway, suggesting alteration in oxidative stress burden. There were no differences in genes or pathways between loss of responders and those who were TNFα-naïve. However, loss of response occurred despite the ability of anti-TNFα therapy to normalize APO gene expression.ConclusionOur analyses suggest that loss of response to anti-TNFα is not driven by the emergence of pathways that bypass the action or induce resistance to anti-TNFα therapy. More... »

PAGES

738-745

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s10620-018-4932-8

DOI

http://dx.doi.org/10.1007/s10620-018-4932-8

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1100620886

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/29372477


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adalimumab", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Anti-Inflammatory Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Crohn Disease", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Tolerance", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Gastrointestinal Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Infliximab", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Intracellular Signaling Peptides and Proteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Oxidative Stress", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Remission Induction", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tumor Necrosis Factor-alpha", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Young Adult", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Gastrointestinal Unit, Massachusetts General Hospital, Harvard Medical School, Blake 4, 55 Fruit Street, 02114, Boston, MA, USA", 
          "id": "http://www.grid.ac/institutes/grid.32224.35", 
          "name": [
            "Gastrointestinal Unit, Massachusetts General Hospital, Harvard Medical School, Blake 4, 55 Fruit Street, 02114, Boston, MA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Luther", 
        "givenName": "Jay", 
        "id": "sg:person.0616021630.11", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0616021630.11"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Gastrointestinal Unit, Massachusetts General Hospital, Harvard Medical School, Blake 4, 55 Fruit Street, 02114, Boston, MA, USA", 
          "id": "http://www.grid.ac/institutes/grid.32224.35", 
          "name": [
            "Gastrointestinal Unit, Massachusetts General Hospital, Harvard Medical School, Blake 4, 55 Fruit Street, 02114, Boston, MA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gala", 
        "givenName": "Manish", 
        "id": "sg:person.01257350347.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01257350347.03"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Gastrointestinal Unit, Massachusetts General Hospital, Harvard Medical School, Blake 4, 55 Fruit Street, 02114, Boston, MA, USA", 
          "id": "http://www.grid.ac/institutes/grid.32224.35", 
          "name": [
            "Gastrointestinal Unit, Massachusetts General Hospital, Harvard Medical School, Blake 4, 55 Fruit Street, 02114, Boston, MA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Patel", 
        "givenName": "Suraj J.", 
        "id": "sg:person.016453605447.50", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016453605447.50"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medicine, Case Western Reserve University, Cleveland, OH, USA", 
          "id": "http://www.grid.ac/institutes/grid.67105.35", 
          "name": [
            "Department of Medicine, Case Western Reserve University, Cleveland, OH, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Dave", 
        "givenName": "Maneesh", 
        "id": "sg:person.01006666671.75", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01006666671.75"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Gastrointestinal Unit, Massachusetts General Hospital, Harvard Medical School, Blake 4, 55 Fruit Street, 02114, Boston, MA, USA", 
          "id": "http://www.grid.ac/institutes/grid.32224.35", 
          "name": [
            "Gastrointestinal Unit, Massachusetts General Hospital, Harvard Medical School, Blake 4, 55 Fruit Street, 02114, Boston, MA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Borren", 
        "givenName": "Nynke", 
        "id": "sg:person.016072572645.26", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016072572645.26"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Gastrointestinal Unit, Massachusetts General Hospital, Harvard Medical School, Blake 4, 55 Fruit Street, 02114, Boston, MA, USA", 
          "id": "http://www.grid.ac/institutes/grid.32224.35", 
          "name": [
            "Gastrointestinal Unit, Massachusetts General Hospital, Harvard Medical School, Blake 4, 55 Fruit Street, 02114, Boston, MA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Xavier", 
        "givenName": "Ramnik J.", 
        "id": "sg:person.0717130066.82", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0717130066.82"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Gastrointestinal Unit, Massachusetts General Hospital, Harvard Medical School, Blake 4, 55 Fruit Street, 02114, Boston, MA, USA", 
          "id": "http://www.grid.ac/institutes/grid.32224.35", 
          "name": [
            "Gastrointestinal Unit, Massachusetts General Hospital, Harvard Medical School, Blake 4, 55 Fruit Street, 02114, Boston, MA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ananthakrishnan", 
        "givenName": "Ashwin N.", 
        "id": "sg:person.01162263474.10", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01162263474.10"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/ajg.2008.88", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040472295", 
          "https://doi.org/10.1038/ajg.2008.88"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/ajg.2014.146", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011427101", 
          "https://doi.org/10.1038/ajg.2014.146"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nm0617-788d", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1085880786", 
          "https://doi.org/10.1038/nm0617-788d"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nm.4307", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1084508963", 
          "https://doi.org/10.1038/nm.4307"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2018-01-25", 
    "datePublishedReg": "2018-01-25", 
    "description": "BackgroundWhile monoclonal antibodies against tumor necrosis factor-\u03b1 (TNF\u03b1) are effective in treating Crohn\u2019s disease (CD), approximately one-third of patients lose response. The mechanisms underlying this loss of response remain elusive.AimWe sought to determine if novel biological pathways, including TNF\u03b1-independent inflammatory pathways, emerge in those with loss of response to anti-TNF\u03b1.MethodsUsing RNA microarray technology in 28 patients with CD, we examined the colonic gene expression differences between those with active inflammation in the setting of loss of response to TNF\u03b1-antagonist therapy (\u201closs of responders\u201d) compared to anti-TNF\u03b1 na\u00efve patients with active inflammation and those on anti-TNF therapy in disease remission. Pathway enrichment analyses were performed.ResultsWe found that colonic expression of chemokines known to drive inflammation (CXCL20, CXCL9, and CXCL10) was elevated in those with loss of response compared to those in remission. Expression of genes critical to modulating oxidative stress burden (DUOX2, DUOXA2, and NOS2) was also elevated. Additionally, MMP3, MMP1, and MMP12 were elevated in those with continued inflammation. Gene enrichment analysis revealed that loss of responders exhibited dysregulation in the cysteine and methionine metabolism pathway, suggesting alteration in oxidative stress burden. There were no differences in genes or pathways between loss of responders and those who were TNF\u03b1-na\u00efve. However, loss of response occurred despite the ability of anti-TNF\u03b1 therapy to normalize APO gene expression.ConclusionOur analyses suggest that loss of response to anti-TNF\u03b1 is not driven by the emergence of pathways that bypass the action or induce resistance to anti-TNF\u03b1 therapy.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s10620-018-4932-8", 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2419042", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.3867645", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2439002", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.6664459", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.3805577", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1018525", 
        "issn": [
          "0163-2116", 
          "1573-2568"
        ], 
        "name": "Digestive Diseases and Sciences", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "3", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "63"
      }
    ], 
    "keywords": [
      "loss of response", 
      "anti-TNF\u03b1 therapy", 
      "Crohn's disease", 
      "oxidative stress burden", 
      "active inflammation", 
      "inflammatory pathways", 
      "anti-tumor necrosis factor-alpha therapy", 
      "stress burden", 
      "necrosis factor alpha therapy", 
      "TNF\u03b1 antagonist therapy", 
      "anti-TNF therapy", 
      "novel inflammatory pathway", 
      "tumor necrosis factor", 
      "RNA microarray technology", 
      "continued inflammation", 
      "na\u00efve patients", 
      "disease remission", 
      "colonic expression", 
      "enrichment analysis", 
      "necrosis factor", 
      "alpha therapy", 
      "setting of loss", 
      "inflammation", 
      "methionine metabolism pathway", 
      "ConclusionOur analysis", 
      "therapy", 
      "patients", 
      "novel biological pathways", 
      "monoclonal antibodies", 
      "disease", 
      "pathway enrichment analysis", 
      "remission", 
      "gene enrichment analysis", 
      "expression of genes", 
      "one-third", 
      "responders", 
      "gene expression differences", 
      "metabolism pathways", 
      "burden", 
      "pathway", 
      "expression", 
      "gene expression", 
      "response", 
      "biological pathways", 
      "expression differences", 
      "chemokines", 
      "AimWe", 
      "TNF\u03b1", 
      "MMP12", 
      "MMP3", 
      "antibodies", 
      "ResultsWe", 
      "MMP1", 
      "dysregulation", 
      "loss", 
      "microarray technology", 
      "differences", 
      "genes", 
      "alterations", 
      "setting", 
      "factors", 
      "analysis", 
      "action", 
      "resistance", 
      "mechanism", 
      "cysteine", 
      "emergence of pathways", 
      "emergence", 
      "ability", 
      "technology"
    ], 
    "name": "Loss of Response to Anti-Tumor Necrosis Factor Alpha Therapy in Crohn\u2019s Disease Is Not Associated with Emergence of Novel Inflammatory Pathways", 
    "pagination": "738-745", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1100620886"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s10620-018-4932-8"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "29372477"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s10620-018-4932-8", 
      "https://app.dimensions.ai/details/publication/pub.1100620886"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-09-02T16:01", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/article/article_772.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s10620-018-4932-8"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s10620-018-4932-8'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s10620-018-4932-8'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s10620-018-4932-8'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s10620-018-4932-8'


 

This table displays all metadata directly associated to this object as RDF triples.

258 TRIPLES      21 PREDICATES      113 URIs      101 LITERALS      21 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s10620-018-4932-8 schema:about N1ce040cc64ce4a52a766bdaea7215fe5
2 N1f544310764d43b19c820ffc018edfaf
3 N208049db19514fbc9a451e3bdef769c0
4 N2085348985684c6f8810727f1dad485a
5 N22fd56bff16e496abd5e0d9add0ff704
6 N2fb2c083756644b98ed591bf3af94f45
7 N33b266269bad4cb39ed886c2080e1d1d
8 N40da5c673c2e4046b7845e4e57038113
9 N4c1dc66415c04660949b1b5981b027f0
10 N7b4bb98ce3ed4ddb8ac9065cb2de3c2e
11 N8aa58bb11dc9457d811d9ff4a89372e6
12 Nb8b705cb54f04015bc321c1f45663937
13 Nf29160df9a0f42f594f3e5cad2fbbe0e
14 Nf2f83fd0b9624a43949bd3ee084df5e7
15 anzsrc-for:11
16 anzsrc-for:1102
17 schema:author N81a24702c9194588890e8cd6e243fce9
18 schema:citation sg:pub.10.1038/ajg.2008.88
19 sg:pub.10.1038/ajg.2014.146
20 sg:pub.10.1038/nm.4307
21 sg:pub.10.1038/nm0617-788d
22 schema:datePublished 2018-01-25
23 schema:datePublishedReg 2018-01-25
24 schema:description BackgroundWhile monoclonal antibodies against tumor necrosis factor-α (TNFα) are effective in treating Crohn’s disease (CD), approximately one-third of patients lose response. The mechanisms underlying this loss of response remain elusive.AimWe sought to determine if novel biological pathways, including TNFα-independent inflammatory pathways, emerge in those with loss of response to anti-TNFα.MethodsUsing RNA microarray technology in 28 patients with CD, we examined the colonic gene expression differences between those with active inflammation in the setting of loss of response to TNFα-antagonist therapy (“loss of responders”) compared to anti-TNFα naïve patients with active inflammation and those on anti-TNF therapy in disease remission. Pathway enrichment analyses were performed.ResultsWe found that colonic expression of chemokines known to drive inflammation (CXCL20, CXCL9, and CXCL10) was elevated in those with loss of response compared to those in remission. Expression of genes critical to modulating oxidative stress burden (DUOX2, DUOXA2, and NOS2) was also elevated. Additionally, MMP3, MMP1, and MMP12 were elevated in those with continued inflammation. Gene enrichment analysis revealed that loss of responders exhibited dysregulation in the cysteine and methionine metabolism pathway, suggesting alteration in oxidative stress burden. There were no differences in genes or pathways between loss of responders and those who were TNFα-naïve. However, loss of response occurred despite the ability of anti-TNFα therapy to normalize APO gene expression.ConclusionOur analyses suggest that loss of response to anti-TNFα is not driven by the emergence of pathways that bypass the action or induce resistance to anti-TNFα therapy.
25 schema:genre article
26 schema:isAccessibleForFree true
27 schema:isPartOf N47a4b93a8073498ea5e9b9c2e5cb70dd
28 Nd3597ca8c9c84e2ebd27cb0d1015ee06
29 sg:journal.1018525
30 schema:keywords AimWe
31 ConclusionOur analysis
32 Crohn's disease
33 MMP1
34 MMP12
35 MMP3
36 RNA microarray technology
37 ResultsWe
38 TNFα
39 TNFα antagonist therapy
40 ability
41 action
42 active inflammation
43 alpha therapy
44 alterations
45 analysis
46 anti-TNF therapy
47 anti-TNFα therapy
48 anti-tumor necrosis factor-alpha therapy
49 antibodies
50 biological pathways
51 burden
52 chemokines
53 colonic expression
54 continued inflammation
55 cysteine
56 differences
57 disease
58 disease remission
59 dysregulation
60 emergence
61 emergence of pathways
62 enrichment analysis
63 expression
64 expression differences
65 expression of genes
66 factors
67 gene enrichment analysis
68 gene expression
69 gene expression differences
70 genes
71 inflammation
72 inflammatory pathways
73 loss
74 loss of response
75 mechanism
76 metabolism pathways
77 methionine metabolism pathway
78 microarray technology
79 monoclonal antibodies
80 naïve patients
81 necrosis factor
82 necrosis factor alpha therapy
83 novel biological pathways
84 novel inflammatory pathway
85 one-third
86 oxidative stress burden
87 pathway
88 pathway enrichment analysis
89 patients
90 remission
91 resistance
92 responders
93 response
94 setting
95 setting of loss
96 stress burden
97 technology
98 therapy
99 tumor necrosis factor
100 schema:name Loss of Response to Anti-Tumor Necrosis Factor Alpha Therapy in Crohn’s Disease Is Not Associated with Emergence of Novel Inflammatory Pathways
101 schema:pagination 738-745
102 schema:productId N4cd2e8b7aedd4c1d8b7ab352576aea3a
103 N6dcf2fc40ebf42758bfa32549a0d5559
104 N85204c6502d54b5eb0e6c74532b842f1
105 schema:sameAs https://app.dimensions.ai/details/publication/pub.1100620886
106 https://doi.org/10.1007/s10620-018-4932-8
107 schema:sdDatePublished 2022-09-02T16:01
108 schema:sdLicense https://scigraph.springernature.com/explorer/license/
109 schema:sdPublisher N770465c081e747c4a4317f90ea8d78fa
110 schema:url https://doi.org/10.1007/s10620-018-4932-8
111 sgo:license sg:explorer/license/
112 sgo:sdDataset articles
113 rdf:type schema:ScholarlyArticle
114 N191e8431f4684e4ebc228d25135734f3 rdf:first sg:person.016453605447.50
115 rdf:rest N478812d659d44eb0bd7da6a7b57ce61f
116 N1ce040cc64ce4a52a766bdaea7215fe5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Male
118 rdf:type schema:DefinedTerm
119 N1f544310764d43b19c820ffc018edfaf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Adalimumab
121 rdf:type schema:DefinedTerm
122 N208049db19514fbc9a451e3bdef769c0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Anti-Inflammatory Agents
124 rdf:type schema:DefinedTerm
125 N2085348985684c6f8810727f1dad485a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Humans
127 rdf:type schema:DefinedTerm
128 N22fd56bff16e496abd5e0d9add0ff704 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Gastrointestinal Agents
130 rdf:type schema:DefinedTerm
131 N2fb2c083756644b98ed591bf3af94f45 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Infliximab
133 rdf:type schema:DefinedTerm
134 N3122e2d5b2154058a26d1f1689ae31b2 rdf:first sg:person.016072572645.26
135 rdf:rest N7d8f05535a524291b36091d413e4f7dd
136 N33b266269bad4cb39ed886c2080e1d1d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Intracellular Signaling Peptides and Proteins
138 rdf:type schema:DefinedTerm
139 N40da5c673c2e4046b7845e4e57038113 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Crohn Disease
141 rdf:type schema:DefinedTerm
142 N478812d659d44eb0bd7da6a7b57ce61f rdf:first sg:person.01006666671.75
143 rdf:rest N3122e2d5b2154058a26d1f1689ae31b2
144 N47a4b93a8073498ea5e9b9c2e5cb70dd schema:issueNumber 3
145 rdf:type schema:PublicationIssue
146 N4c1dc66415c04660949b1b5981b027f0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Female
148 rdf:type schema:DefinedTerm
149 N4cd2e8b7aedd4c1d8b7ab352576aea3a schema:name dimensions_id
150 schema:value pub.1100620886
151 rdf:type schema:PropertyValue
152 N6dcf2fc40ebf42758bfa32549a0d5559 schema:name doi
153 schema:value 10.1007/s10620-018-4932-8
154 rdf:type schema:PropertyValue
155 N76afdf94916f462fb72b485e2f796b5e rdf:first sg:person.01257350347.03
156 rdf:rest N191e8431f4684e4ebc228d25135734f3
157 N770465c081e747c4a4317f90ea8d78fa schema:name Springer Nature - SN SciGraph project
158 rdf:type schema:Organization
159 N7b4bb98ce3ed4ddb8ac9065cb2de3c2e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
160 schema:name Oxidative Stress
161 rdf:type schema:DefinedTerm
162 N7d8f05535a524291b36091d413e4f7dd rdf:first sg:person.0717130066.82
163 rdf:rest Necd921b4a982498f8e1b4d0740ab3a46
164 N81a24702c9194588890e8cd6e243fce9 rdf:first sg:person.0616021630.11
165 rdf:rest N76afdf94916f462fb72b485e2f796b5e
166 N85204c6502d54b5eb0e6c74532b842f1 schema:name pubmed_id
167 schema:value 29372477
168 rdf:type schema:PropertyValue
169 N8aa58bb11dc9457d811d9ff4a89372e6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
170 schema:name Drug Tolerance
171 rdf:type schema:DefinedTerm
172 Nb8b705cb54f04015bc321c1f45663937 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
173 schema:name Young Adult
174 rdf:type schema:DefinedTerm
175 Nd3597ca8c9c84e2ebd27cb0d1015ee06 schema:volumeNumber 63
176 rdf:type schema:PublicationVolume
177 Necd921b4a982498f8e1b4d0740ab3a46 rdf:first sg:person.01162263474.10
178 rdf:rest rdf:nil
179 Nf29160df9a0f42f594f3e5cad2fbbe0e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
180 schema:name Remission Induction
181 rdf:type schema:DefinedTerm
182 Nf2f83fd0b9624a43949bd3ee084df5e7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
183 schema:name Tumor Necrosis Factor-alpha
184 rdf:type schema:DefinedTerm
185 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
186 schema:name Medical and Health Sciences
187 rdf:type schema:DefinedTerm
188 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
189 schema:name Cardiorespiratory Medicine and Haematology
190 rdf:type schema:DefinedTerm
191 sg:grant.2419042 http://pending.schema.org/fundedItem sg:pub.10.1007/s10620-018-4932-8
192 rdf:type schema:MonetaryGrant
193 sg:grant.2439002 http://pending.schema.org/fundedItem sg:pub.10.1007/s10620-018-4932-8
194 rdf:type schema:MonetaryGrant
195 sg:grant.3805577 http://pending.schema.org/fundedItem sg:pub.10.1007/s10620-018-4932-8
196 rdf:type schema:MonetaryGrant
197 sg:grant.3867645 http://pending.schema.org/fundedItem sg:pub.10.1007/s10620-018-4932-8
198 rdf:type schema:MonetaryGrant
199 sg:grant.6664459 http://pending.schema.org/fundedItem sg:pub.10.1007/s10620-018-4932-8
200 rdf:type schema:MonetaryGrant
201 sg:journal.1018525 schema:issn 0163-2116
202 1573-2568
203 schema:name Digestive Diseases and Sciences
204 schema:publisher Springer Nature
205 rdf:type schema:Periodical
206 sg:person.01006666671.75 schema:affiliation grid-institutes:grid.67105.35
207 schema:familyName Dave
208 schema:givenName Maneesh
209 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01006666671.75
210 rdf:type schema:Person
211 sg:person.01162263474.10 schema:affiliation grid-institutes:grid.32224.35
212 schema:familyName Ananthakrishnan
213 schema:givenName Ashwin N.
214 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01162263474.10
215 rdf:type schema:Person
216 sg:person.01257350347.03 schema:affiliation grid-institutes:grid.32224.35
217 schema:familyName Gala
218 schema:givenName Manish
219 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01257350347.03
220 rdf:type schema:Person
221 sg:person.016072572645.26 schema:affiliation grid-institutes:grid.32224.35
222 schema:familyName Borren
223 schema:givenName Nynke
224 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016072572645.26
225 rdf:type schema:Person
226 sg:person.016453605447.50 schema:affiliation grid-institutes:grid.32224.35
227 schema:familyName Patel
228 schema:givenName Suraj J.
229 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016453605447.50
230 rdf:type schema:Person
231 sg:person.0616021630.11 schema:affiliation grid-institutes:grid.32224.35
232 schema:familyName Luther
233 schema:givenName Jay
234 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0616021630.11
235 rdf:type schema:Person
236 sg:person.0717130066.82 schema:affiliation grid-institutes:grid.32224.35
237 schema:familyName Xavier
238 schema:givenName Ramnik J.
239 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0717130066.82
240 rdf:type schema:Person
241 sg:pub.10.1038/ajg.2008.88 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040472295
242 https://doi.org/10.1038/ajg.2008.88
243 rdf:type schema:CreativeWork
244 sg:pub.10.1038/ajg.2014.146 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011427101
245 https://doi.org/10.1038/ajg.2014.146
246 rdf:type schema:CreativeWork
247 sg:pub.10.1038/nm.4307 schema:sameAs https://app.dimensions.ai/details/publication/pub.1084508963
248 https://doi.org/10.1038/nm.4307
249 rdf:type schema:CreativeWork
250 sg:pub.10.1038/nm0617-788d schema:sameAs https://app.dimensions.ai/details/publication/pub.1085880786
251 https://doi.org/10.1038/nm0617-788d
252 rdf:type schema:CreativeWork
253 grid-institutes:grid.32224.35 schema:alternateName Gastrointestinal Unit, Massachusetts General Hospital, Harvard Medical School, Blake 4, 55 Fruit Street, 02114, Boston, MA, USA
254 schema:name Gastrointestinal Unit, Massachusetts General Hospital, Harvard Medical School, Blake 4, 55 Fruit Street, 02114, Boston, MA, USA
255 rdf:type schema:Organization
256 grid-institutes:grid.67105.35 schema:alternateName Department of Medicine, Case Western Reserve University, Cleveland, OH, USA
257 schema:name Department of Medicine, Case Western Reserve University, Cleveland, OH, USA
258 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...